The pursuit for potent therapies necessitates identification of novel therapeutic targets . This analysis highlights current advancements in identifying and establishing such focuses – moving beyond conventional pathways to tackle unmet patient needs. Specifically , we consider targets involved in complex disease pathways, including imbalances in